CLASS II Device recall · Reported 26 May 2021 · FDA Enforcement Report

Eluvia Drug-Eluting Vascular Stent System recalled by Boston Scientific

Boston Scientific is recalling Eluvia Drug-Eluting Vascular Stent System, distributed nationwide in the US. The recall was initiated on 21 Apr 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLOT: 25838357
Quantity recalled27 UNITS

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1621-2021
FDA event ID
87839
Recalling firm
Boston Scientific, Maple Grove, MN
Classification
Class II
Status
Terminated
Recall initiated
21 Apr 2021
FDA classified
18 May 2021
Reported
26 May 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

21 Apr 2021Recall initiated by company
18 May 2021Classified by FDA+27 days
26 May 2021Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

One batch of the ELUVIATM Drug Eluting Vascular Stent System incorrect placement of some 6x40mm ELUVIA stents into 6x100mm packaging.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

ELUVIA Drug-Eluting Vascular Stent System - Product Usage: indicated for improving luminal diameter in the treatment of symptomatic de-novo or restenotic lesions in the native superficial femoral artery (SFA) and/or proximal popliteal artery with reference vessel diameters (RVD) ranging from 4.0-6.0 mm and total lesion lengths up to 190 mm.

Where it was distributed

US Nationwide distribution in the states of AL, AR, AZ, CA, DE, HI, IL, KS, KY, MA, MD, NC, NJ, NV, NY, OH, OK, PA,PR, TX, VA,WA,WV.

Nationwide AlabamaArkansasArizonaCaliforniaDelawareHawaiiIllinoisKansasKentuckyMassachusettsMarylandNorth CarolinaNew JerseyNevadaNew YorkOhioOklahomaPennsylvaniaPuerto RicoTexas

Questions about this recall

Why was it recalled?

One batch of the ELUVIATM Drug Eluting Vascular Stent System incorrect placement of some 6x40mm ELUVIA stents into 6x100mm packaging.

Which lots are affected?

LOT: 25838357

Where was it sold?

US Nationwide distribution in the states of AL, AR, AZ, CA, DE, HI, IL, KS, KY, MA, MD, NC, NJ, NV, NY, OH, OK, PA,PR, TX, VA,WA,WV.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Boston Scientific

All 626

Other Heart & Vascular Devices recalls

All 6,199